These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12375010)

  • 1. Sequencing hormonal ablation and radiotherapy in prostate cancer: a molecular and therapeutic prespective (Review).
    Hill B; Kyprianou N
    Oncol Rep; 2002; 9(6):1151-6. PubMed ID: 12375010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and other mechanisms in androgen ablation treatment and androgen independent progression of prostate cancer: a review.
    Westin P; Bergh A
    Cancer Detect Prev; 1998; 22(5):476-84. PubMed ID: 9727630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
    BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications of the association of radiotherapy and hormonal treatment in prostate cancer].
    Bolla M; Maingon P; Fourneret P; Artignan X; Descotes JL
    Cancer Radiother; 2005 Nov; 9(6-7):394-8. PubMed ID: 16226044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
    Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
    Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S; Singh TR; Srivastava RK
    Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review).
    Szostak MJ; Kyprianou N
    Oncol Rep; 2000; 7(4):699-706. PubMed ID: 10854529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary hormonal therapy for advanced prostate cancer.
    Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
    J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure after primary radiation or surgery for prostate cancer: differences in response to androgen ablation.
    Swanson GP; Riggs M; Earle J
    J Urol; 2004 Aug; 172(2):525-8. PubMed ID: 15247720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
    Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.
    Wang G; Sadar MD
    J Cell Biochem; 2006 May; 98(1):36-53. PubMed ID: 16440300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.